Catalyst Wire Dossier Catalyst Wire Dossier

Transdermal oxybutynin

oxybutynin · Watson Pharmaceuticals
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Transdermal oxybutynin, covering 2009-12-23 to 2009-12-23. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy Study of Transdermal Oxybutynin to Treat Overactive Bladder With a Neurological Condition [Phase 4]

See pricing